Inhibition of the JAK/STAT pathway is known to promote apoptosis and reduce cisplatin resistance in gastric cancer [46], while the JAK/STAT pathway also supports CSC self-renewal, leading to chemoresistance [47]. Here, SOAT1 is linked to gastric cancer.